Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

JAK inhibitors show promise for treating various skin diseases.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

A well-equipped resident's bag enhances clinical skills, preparation, confidence, and learning for junior doctors.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

GLPLS and LPP are variants of lichen planus.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Both lasers are equally effective and safe for treating freckles.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

The document concludes that understanding tissue degeneration is crucial for diagnosing skin lesions.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.